Core Scientific, Financials
| CORZZ Stock | 14.10 0.29 2.02% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | 0.1986 |
|
|
Investors should never underestimate Core Scientific,'s ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Core Scientific,'s cash flow, debt, and profitability to make informed and accurate decisions about investing in Core Scientific, Tranche.
Net Income |
|
Core | Select Account or Indicator |
Understanding current and past Core Scientific, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Core Scientific,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Core Scientific,'s assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Core Scientific,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Scientific, Tranche. Check Core Scientific,'s Beneish M Score to see the likelihood of Core Scientific,'s management manipulating its earnings.
Core Scientific, Stock Summary
Core Scientific, competes with SentinelOne, BlackBerry, Global Blue, Aurora Mobile, and Marqeta. Core Scientific, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Technology, Software - Infrastructure |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 21874A130 |
| Location | Texas; U.S.A |
| Business Address | 838 Walker Road, |
| Sector | Technology |
| Industry | Software - Infrastructure |
| Benchmark | Dow Jones Industrial |
| Website | corescientific.com |
| Phone | 512 402 5233 |
Core Scientific, Key Financial Ratios
| Profit Margin | (2.23) % | ||||
| Operating Margin | (0.43) % | ||||
| Revenue | 502.4 M | ||||
| EBITDA | (63.12 M) | ||||
| Net Income | (246.49 M) |
Core Scientific, Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Intangible Assets | 6.7M | 8.2M | 1.7M | 2.2M | 2.0M | 3.6M |
Core Scientific, Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Core Scientific, Tranche. It measures of how well Core is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Core Scientific, brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Core had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Core Scientific, has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 1.6M | 59.3M | 601.7M | 16.2M | 18.6M | 17.7M | |
| End Period Cash Flow | 8.7M | 131.7M | 52.2M | 69.7M | 80.2M | 59.2M |
Core Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Core Scientific,'s current stock value. Our valuation model uses many indicators to compare Core Scientific, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Core Scientific, competition to find correlations between indicators driving Core Scientific,'s intrinsic value. More Info.Core Scientific, Tranche is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . At this time, Core Scientific,'s Net Loss is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Core Scientific,'s earnings, one of the primary drivers of an investment's value.Core Scientific, Tranche Systematic Risk
Core Scientific,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Core Scientific, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Core Scientific, Tranche correlated with the market. If Beta is less than 0 Core Scientific, generally moves in the opposite direction as compared to the market. If Core Scientific, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Core Scientific, Tranche is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Core Scientific, is generally in the same direction as the market. If Beta > 1 Core Scientific, moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Core Scientific, is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Core has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Core Scientific,'s financials are consistent with your investment objective using the following steps:- Review Core Scientific,'s balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Core Scientific,'s liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Core Scientific,'s financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Core Scientific,'s stock is overvalued or undervalued.
Today, most investors in Core Scientific, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Core Scientific,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Core Scientific, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Core Scientific, December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Core Scientific, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Core Scientific, Tranche. We use our internally-developed statistical techniques to arrive at the intrinsic value of Core Scientific, Tranche based on widely used predictive technical indicators. In general, we focus on analyzing Core Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Core Scientific,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 3.72 | |||
| Information Ratio | 0.0822 | |||
| Maximum Drawdown | 25.63 | |||
| Value At Risk | (4.99) | |||
| Potential Upside | 7.74 |
Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.